Hh And L Acquisition Co 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Hh And L Acquisition Co in the third quarter 2023?
Due to the lack of equity, it was not possible to calculate Hh And L Acquisition Co 's return on equity (ROE) in its third quarter 2023

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-33.56 %	-90.5 %	-	-62 %
Net Income (TTM) in Millions	-1	9	9	18	12
Return On Equity (TTM)	-	-	-	-	-
HHLAU's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-15	-14	-14	-12	-19
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	73.53 %	-38.03 %	-70.37 %	108.48 %

Back to HHLAU Management Effectiveness >> HHLAU's 5 Years Annual ROE >> Compare HHLAU ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

HHLAU Annual Return On Equity	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	-12	-32	0	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	18	1	0	0	0
Y / Y Net Income Change	1239.86 %	-	-	-	-
Return On Equity	-	-	-	-	-

Back to HHLAU Management Effectiveness >> HHLAU's 5 Years Annual ROE >> Compare HHLAU ROE to its Competitors

Annual Roe Comment

In 2022 ROE improved to 1239.86 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HHLAU's' Return on Equity at Yahoo Finance
HHLAU's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HHLAU's Competitors
Subscribers only: Roe for Hh And L Acquisition Co 's Suppliers
Subscribers only: Return On Equity for HHLAU's Customers

Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector	ROE
Pfizer Inc	10.69 %
Merck and Co Inc	10.67 %
Neurocrine Biosciences Inc	10.54 %
Dynavax Technologies Corporation	10.46 %
Biogen Inc	10.42 %
U S Physical Therapy Inc	10.34 %
Pediatrix Medical Group Inc	10.08 %
Align Technology inc	9.99 %
The Pennant Group Inc	9.90 %
Fonar Corporation	9.83 %
Lemaitre Vascular Inc	9.78 %
Teleflex Incorporated	9.69 %
Incyte Corporation	9.19 %
Steris Plc	8.99 %
Viemed Healthcare Inc	8.97 %
Atrion Corporation	8.89 %
Hologic Inc	8.86 %
Electromed Inc	8.85 %
Addus Homecare Corp	8.77 %
Viatris Inc	8.75 %
Cervomed Inc	8.72 %
Exelixis Inc	8.68 %
Innoviva Inc	8.64 %
Merit Medical Systems Inc	8.44 %
Schrodinger Inc	7.99 %
Medtronic Plc	7.96 %
Lifevantage Corp	7.94 %
Phibro Animal Health Corporation	7.61 %
Conmed Corporation	7.54 %
Lftd Partners Inc	7.41 %

Date modified: 2026-09-26T07:39:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.